Line graph

Market Insights

Trends & insights to help you understand markets and industries.

The outlook for private equity investment in healthcare in 2025 and beyond
The outlook for private equity investment in healthcare in 2025 and beyond

At the 11th Annual Cain Brothers Private Company Healthcare Conference in New York, Matt Margulies, Managing Director at Cain Brothers, moderated a panel about recovering M&A markets and unique private equity investment perspectives for 2025.

Beyond COVID-19: How digital transformation is reshaping healthcare
Beyond COVID-19: How digital transformation is reshaping healthcare

In the post-pandemic era, healthcare organizations find themselves facing a new set of challenges, including skilled worker burnout, high turnover, and increasing expenses. Many are turning to innovations such as artificial intelligence (AI) and automation, not only to overcome these obstacles but to help streamline operations and simplify internal processes.

2025 Outlook: Meet the New Boss. Same as the Old Boss?
2025 Outlook: Meet the New Boss. Same as the Old Boss?

See how our leading experts interpret the news, trends, and opportunities this year already brings. In our 2025 market outlook, our Key Wealth Chief Investment Office team delves into the latest research and insights to help you navigate our evolving political landscape, inflation, tariffs, immigration, deregulation, tax policy, interest rates, and market and economic data so you can make informed decisions and grow your portfolio.

Knowing your options: Lenders must run multiple scenarios to close the deal
Knowing your options: Lenders must run multiple scenarios to close the deal

Regardless of where rates are headed, lenders must quote deals in multiple ways to meet the client’s needs.

The economy is heading into 2025 on solid footing, but changes in Washington and geopolitical risks abroad raise questions
The economy is heading into 2025 on solid footing, but changes in Washington and geopolitical risks abroad raise questions

Heading into 2025, a variety of factors could reinforce or derail positive sentiment among business leaders, including shifts in political power, decreasing interest rates, geopolitical turmoil and others.

Key Perspectives - Economic Outlook
Key Perspectives - Economic Outlook

Each quarter, KeyBank’s Director of Applied Economics and Analytics Ben Demko breaks down recent data focused on macroeconomic, industry, and market risks for stress testing, loss estimation, asset management, resource allocation, and profit planning. The results are used in our Economic Outlook newsletter.

Inflation in focus: How middle market leaders are responding
Inflation in focus: How middle market leaders are responding

Inflation is pushing business leaders to make tough decisions about how to move forward. Rising costs and shrinking profit margins are creating uncertainty, while the need for increased productivity through technology and process improvements is more crucial than ever. 

What’s happening to Medicare Advantage? A panel discussion
What’s happening to Medicare Advantage? A panel discussion

Medicare Advantage is in the news. A once highly attractive, fast-growing market has whipsawed dramatically, leaving stakeholders uncertain about immediate prospects, longer-term consequences, and the future of the program. To discuss these developments, we enlisted leaders from Cain Brothers’ managed care team.

The Future of B2B Embedded Payments
The Future of B2B Embedded Payments

If you’ve ever booked a ride with Uber or shopped on Amazon, you’ve used embedded payments. Rather than manually entering credit card information or leaving the merchant’s website or app to complete a transaction, users pay with embedded payments by clicking a button, like Apple Pay or Google Pay.

The potential of large-molecule drugs and how technology investments can help tap it
The potential of large-molecule drugs and how technology investments can help tap it

The pharmaceutical market is broken down into two categories: small-molecule drugs, which are derived from chemicals created in a lab, and large-molecule drugs, which are extracted from living organisms. 

Health systems, private equity, and the government: It’s complicated
Health systems, private equity, and the government: It’s complicated

Is private equity the cause of or the solution to all of healthcare’s problems? Wyatt Ritchie, Group Head and Managing Director of Cain Brothers, a division of KeyBanc Capital Markets, joins Dave Johnson, CEO of 4sight Health, for a conversation about private equity’s role in healthcare transformation.

The Great Grid Rush: A frantic scramble for power
The Great Grid Rush: A frantic scramble for power

At the intersection of business growth, climate change and unprecedented power demand, it’s imperative to revolutionize our power infrastructure. But what does that look like? Here we explore the current state of load growth, critical resources to meet the demand, and challenges that must be addressed before it’s too late.

Back to Top

Debt Capital Markets

Full-Service, Debt-Side Investment Solutions

Stock exchange
Full-Service, Debt-Side Investment Solutions

Healthcare

Healthcare Organization Financing Options

Doctor reviewing chart
Healthcare Organization Financing Options

Mitigate Risks

Resources to Help Minimize your Organization’s Risk

Laptop with overlay of email icons
Resources to Help Minimize your Organization’s Risk

Connect With Us

Find an Expert